Popular Articles

Bringing Online Care Plan Tool To Cancer Survivors
The Lance Armstrong Foundation (LAF) and Penn Medicine have announced a four-year partnership to further develop and disseminate the LIVESTRONG Care Plan Powered by Penn Medicine"s OncoLink. This free service gives cancer survivors, their families and physicians the ability to create an individualized plan of care using up-to-date treatment information based on Institute of Medicine recommendations, as well educating them about their options to maintain optimal health once they are out of treatment.
new payday loan lenders
Medical Defence Union's New Scottish Recruits Help Meet Doctors' Demands For Medico-Legal Advice, UK
The Medical Defence Union (MDU) has recruited three new medico-legal advisers in Scotland, bringing its team of experts north of the border to nine - its biggest ever team in the country.
News of the day
H1N1: What You Should Know
As a Dallas-based physician, there has been a recent flurry of panic about the H1N1 (swine influenza). School districts closed down. Intramural sports statewide were cancelled. Some even suggested closing the border with Mexico, where approximately three quarters of a million people routinely cross back and forth every day. The panic certainly was fueled by the media reports. Likewise, the media can serve to educate the public about health issues.
Cardiovascular

Repeated Stress Signals Made In Cells With Metabolism-Associated Disease Encourage The Growth Of Invading Bacteria

Mitochondrial diseases disrupt the power generating machinery within cells and increase a person"s susceptibility to bacterial infection, particularly in the lungs or respiratory tract. A new study published in Disease Models & Mechanisms (DMM), shows that infection with the pneumonia causing bacteria Legionella, is facilitated by an increased amount of a signaling protein that is associated with mitochondrial disease. Patients with mitochondrial disease exhibit a wide range of symptoms including diabetes, blindness, deafness, stroke-like episodes, epilepsy, ataxia, muscle weakness and kidney disease. The metabolic abnormalities that cause these effects also induce a stress signal intended to help the body overcome its energy deficit. The stress-signal induces the production of more mitochondria, the energy generating "powerplants" of the body, in the hopes that more mitochondria will result in a better power supply. Researchers now show that the stress-signal associated with mitochondrial disease facilitates the growth and reproduction of the lung-infecting bacteria, Legionella. Cells with mitochondrial disease increase their production of a signaling protein called AMP-activated protein kinase (AMPK), to promote the generation of more energy producing mitochondria. Infectious bacteria, like Legionella, target the mitochondria and might use them to supplement their own needs and survival requirements. By manipulating AMPK levels, scientists were able to directly influence the ability of bacteria to replicate inside of the single-celled organism, Dictyostelium. Striking similarities that exist between simple organisms like Dictyostelium and humans allow scientists to use them to understand human disease. Dictyostelium is a free-living amoeba whose rapid movements make it useful to study motility and energy regulation, and in this case, the association between energy regulation and susceptibility to infection. Like humans, Dictyostelium can be infected by Legionella and quickly responds by producing a host of metabolism-associated proteins. Another similarity between humans and Dictyostelium is that both use AMPK as an internal sensor to coordinate energy synthesis with energy needs. However, unlike humans, researchers can infect Dictyostelium with germs like Legionella in a controlled environment and determine the influence of various parameters on the course of infection. The report titled "Legionella pneumophila multiplication is enhanced by chronic AMPK signalling in mitochondrially diseased cells" was written by Lisa Francione, Paige K. Smith, Sandra L. Accari, Paul B. Bokko and Paul Fisher at La Trobe Univeristy in Australia, Salvatore Bozzaro at University of Turin in Italy and Phillip E Taylor and Peter L. Beech at Deakin University in Australia. The study is published in the September/October 2009 issue of the new research journal, Disease Models & Mechanisms (DMM), published by The Company of Biologists, a non-profit based in Cambridge, UK. Kristy Kain The Company of Biologists


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):